FC

Finepoint Capital Portfolio holdings

AUM $543M
1-Year Est. Return 12.25%
This Quarter Est. Return
1 Year Est. Return
+12.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$504M
AUM Growth
-$88.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
25
New
Increased
Reduced
Closed

Top Buys

1 +$8.45M

Top Sells

1 +$71.4M
2 +$45M
3 +$32.2M
4
ASND icon
Ascendis Pharma
ASND
+$28M
5
RVMD icon
Revolution Medicines
RVMD
+$24.4M

Sector Composition

1 Industrials 90.35%
2 Communication Services 8.64%
3 Healthcare 0.93%
4 Energy 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QXO
1
QXO Inc
QXO
$11.8B
$456M 33.61%
21,152,868
-3,315,292
LLYVK icon
2
Liberty Live Group Series C
LLYVK
$7.68B
$43.6M 3.22%
537,051
+104,156
SLDB icon
3
Solid Biosciences
SLDB
$330M
$4.68M 0.35%
961,251
ANNA
4
AleAnna Inc
ANNA
$134M
$200K 0.01%
27,717
ANNAW
5
AleAnna Inc Warrant
ANNAW
$115K 0.01%
490,000
MNYWW
6
MoneyHero Ltd Warrants
MNYWW
$1.39M
$41.9K ﹤0.01%
895,000
LSBPW
7
DELISTED
LakeShore Biopharma Warrants
LSBPW
$19.6K ﹤0.01%
489,999
CLDI icon
8
Calidi Biotherapeutics
CLDI
$8.02M
$2.88K ﹤0.01%
1,042
RVMD icon
9
Revolution Medicines
RVMD
$13.1B
-691,260
ARVN icon
10
Arvinas
ARVN
$679M
-694,028
ASND icon
11
Ascendis Pharma
ASND
$12.5B
-179,872
CYTK icon
12
Cytokinetics
CYTK
$8.12B
-309,948
EYPT icon
13
EyePoint Pharmaceuticals
EYPT
$959M
-1,081,954
GLPG icon
14
Galapagos
GLPG
$2.06B
-656,587
IWM icon
15
iShares Russell 2000 ETF
IWM
$68.2B
0
LBRDK icon
16
Liberty Broadband Class C
LBRDK
$6.75B
-529,240
MLTX icon
17
MoonLake Immunotherapeutics
MLTX
$905M
-435,785
PRTA icon
18
Prothena Corp
PRTA
$535M
-640,071
RLAY icon
19
Relay Therapeutics
RLAY
$1.09B
-2,117,646
RNA icon
20
Avidity Biosciences
RNA
$10.7B
-380,700
SPY icon
21
SPDR S&P 500 ETF Trust
SPY
$667B
0
SRPT icon
22
Sarepta Therapeutics
SRPT
$1.97B
-157,555
SWTX
23
DELISTED
SpringWorks Therapeutics
SWTX
-728,602
XNCR icon
24
Xencor
XNCR
$1.07B
-642,200
GATEW
25
DELISTED
Marblegate Acquisition Corp. Warrant
GATEW
-735,000